Network origin in Greg Zarbis-Papastoitsis first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Greg Zarbis-Papastoitsis via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| Washington University in St. Louis | College/University | Graduate Degree Undergraduate Degree | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer Corporate Officer/Principal | |
| SATCON TECHNOLOGY CORPORATION | Semiconductors | Comptroller/Controller/Auditor | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| DYAX CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| BRAINSTORM CELL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
| DNIB UNWIND INC | Biotechnology | Director/Board Member Chairman | |
| GELESIS INC | Biotechnology | Director/Board Member | |
Cerapedics, Inc.
 Cerapedics, Inc. Pharmaceuticals: MajorHealth Technology Cerapedics, Inc. engaged in the provision of developing and commercializing novel osteobiologic products. It offers i-FACTOR Bone Graft, an advanced biologic that supported with level I evidence, and provides benefit ratio. The company was founded by Andrew J. Tofe and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
Novalere, Inc.
 Novalere, Inc. Pharmaceuticals: MajorHealth Technology Novalere, Inc. develops pharmaceutical products. The company is headquartered in Newton, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Chairman | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree | |
| The University of Chicago | College/University | Masters Business Admin | |
| University of Vermont | College/University | Undergraduate Degree | |
| The State University of New York | College/University | Doctorate Degree | |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| XT Hi- Tech Investments (1992) Ltd. | Corporate Officer/Principal | ||
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
New England Eye Center
 New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
Alliance for Cancer Gene Therapy, Inc.
 Alliance for Cancer Gene Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Alliance for Cancer Gene Therapy, Inc. provides funding for cancer research. The non-profit company is based in Stamford, CT. The company was founded by Edward Netter. Kevin Honeycutt has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member | |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Arthur Anderson & Co. | Corporate Officer/Principal | ||
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Chairman | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal | |
| Tufts University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
| United States | 42 |
| Israel | 5 |
| United Kingdom | 2 |
| France | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 34 |
| Consumer Services | 7 |
| Finance | 4 |
| Commercial Services | 3 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 168 |
| Corporate Officer/Principal | 82 |
| Chairman | 60 |
| Founder | 49 |
| Independent Dir/Board Member | 49 |
Most connected contacts
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Daniel Lynch | 32 |
| Mark Levin | 26 |
| Wendy Dixon | 25 |
| Jane Henderson | 25 |
| Burt Adelman | 23 |
| Abbie Celniker | 23 |
| Chen Schor | 23 |
| Cameron Wheeler | 20 |
| Gregory Perry | 16 |
| Karen L. Tubridy | 13 |
| Michael H. Goldstein | 12 |
| Paul Chaney | 12 |
| Barry Gertz | 9 |
| Eric S. Furfine | 9 |
- Stock Market
- Insiders
- Greg Zarbis-Papastoitsis
- Company connections
